ODAIA is looking forward to taking part in the upcoming NEXT Normal Pharma Summit September event: "Digital Transformation in Pharma- the C-Suite perspective".
NEXT Normal is the ultimate event for CX, commercial excellence, marketing, and medical affairs leaders who want to design better engagement outcomes with HCPs and other stakeholders.
Speakers on this panel include masterminds from pharmaceuticals, digital health companies and tech companies. This includes Orchid Jahanshahi, Vice President of Lifescience at ODAIA and Jérôme de Larosière, Head of Marketing, Rare Diseases at IPSEN. An invitation for the registration can be found here.
ODAIA has innovated the first AI-powered Customer Data Platform (CDP) that pioneered the combination of process mining, customer journey mapping and AI to deliver goal-driven commercial insights and process automation as a SaaS.
ODAIA offers a self-serve platform: MAPTUAL, serving the biopharma industry.
Watch our experts explain how MAPTUAL creates a unified experience with meaningful touchpoints
to better engage with your HCPs.
Want to understand how MAPTUAL really helps pharma companies? Take a look at this analysis of the first six-months one top-10 pharma company had using MAPTUAL. See the challenges, solutions and results and read quotes from users.Download Case Study
For a breakdown of all the necessary support, funds, and other resources, as well as the misconceptions and benefits of building a custom AI solution versus buying a ready-to-use developed product, this infographic gives a breakdown of what you need to know.Download Infographic